301363.SZ
美好医疗
SZSE · C 制造业 · CN
CNY 16.15
−4.21%Year over year
Reported trailing growth
- Revenue
- +7.7%
- EBITDA
- —
- EBIT
- -16.4%
- EPS
- -19.1%
- Free cash flow
- —
- Operating cash flow
- +12.4%
Forward estimates
Based on analyst estimates
- Revenue
- —
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- +4.7%
- EBITDA
- -5.9%
- EBIT
- -10.7%
- Net income
- -11.0%
- EPS
- -22.6%
- Free cash flow
- —
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Mar 1, 2026